Comparison of Three Ultrasmall, Superparamagnetic Iron Oxide Nanoparticles for MRI at 3. 0 T

Autor: Caroline M. Colbert, Zhengyang Ming, Arutyun Pogosyan, J. Paul Finn, Kim‐Lien Nguyen
Rok vydání: 2022
Předmět:
Zdroj: Journal of Magnetic Resonance Imaging. 57:1819-1829
ISSN: 1522-2586
1053-1807
DOI: 10.1002/jmri.28457
Popis: The ultrasmall, superparamagnetic iron oxide (USPIO) nanoparticle ferumoxytol has unique applications in cardiac, vascular, and body magnetic resonance imaging (MRI) due to its long intravascular half-life and suitability as a blood pool agent. However, limited availability and high cost have hindered its clinical adoption. A new ferumoxytol generic, and the emergence of MoldayION as an alternative USPIO, represent opportunities to expand the use of USPIO-enhanced MRI techniques.To compare in vitro and in vivo MRI relaxometry and enhancement of Feraheme, generic ferumoxytol, and MoldayION.Prospective.Ten healthy swine and six swine with artificially induced coronary narrowing underwent cardiac MRI.3.0 T; T1-weighted (4D-MUSIC, 3D-VIBE, 2D-MOLLI) and T2-weighted (2D-HASTE) sequences pre- and post-contrast.We compared the MRI relaxometry of Feraheme, generic ferumoxytol, and MoldayION using saline, plasma, and whole blood MRI phantoms with contrast concentrations from 0.26 mM to 2.10 mM. In-vivo contrast effects on T1- and T2-weighted sequences and fractional intravascular contrast distribution volume in myocardium, liver, and spleen were evaluated.Analysis of variance and covariance were used for group comparisons. A P value0.05 was considered statistically significant.The rRelative to clinically approved ferumoxytol formulations, MoldayION demonstrates minor differences in in vitro relaxometry and comparable in vivo MRI characteristics.2 TECHNICAL EFFICACY: Stage 1.
Databáze: OpenAIRE
Externí odkaz: